Zentek Ltd. — Investor Relations & Filings
Zentek Ltd. is an intellectual property (IP) development and commercialization company specializing in nanotechnology. It leverages expertise in nanomaterials, particularly graphene, to research, develop, and patent advanced solutions for the healthcare, safety, and environmental sectors. The company's primary focus is on creating technologies for prevention, detection, and treatment. Its flagship commercial product is ZenGUARD™, a proprietary graphene-based antimicrobial coating that enhances the pathogen-filtering efficacy of personal protective equipment like surgical masks. Zentek's development pipeline also includes other advanced materials, such as graphite-based fire-retardant products, which it advances toward commercialization through strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-27 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47718185 | FORM 6-K | 2026-05-27 | English | ||
| 45626550 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | ||
| 41929009 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | ||
| 38023632 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | ||
| 35277900 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | ||
| 34650021 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | ||
| 34596920 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English | ||
| 34417504 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-13 | English | ||
| 33135818 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-01 | English | ||
| 33040816 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-03-25 | English | ||
| 32199603 | 6-K Filing | 2026-01-29 | English | ||
|
2025
4 filings
| |||||
| 13569824 | FORM 6-K | 2025-12-17 | English | ||
| 13569823 | FORM 6-K | 2025-11-25 | English | ||
| 13569826 | FORM 6-K | 2025-11-21 | English | ||
| 13569829 | FORM 6-K | 2025-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Keros Therapeutics, Inc.
Develops protein therapeutics for disorders linked to TGF-β…
|
KROS | US | Professional, scientific and te… |
|
KIM FOREST
Offers integrated precision medicine and molecular diagnost…
|
6645 | TW | Professional, scientific and te… |
|
Kura Oncology, Inc.
Clinical-stage biopharma company developing precision medic…
|
KURA | US | Professional, scientific and te… |
|
LAB Research Inc.
Global non-clinical CRO specializing in contract research, …
|
LRI | CA | Professional, scientific and te… |
|
Laekna, Inc.
Clinical-stage biotech developing novel therapies for oncol…
|
2105 | HK | Professional, scientific and te… |
|
Larimar Therapeutics, Inc.
A clinical-stage biotech developing treatments for complex …
|
LRMR | US | Professional, scientific and te… |
|
Lexaria Bioscience Corp.
A biotech company with a patented platform to improve oral …
|
LEXX | US | Professional, scientific and te… |
|
LigaChem Biosciences Inc.
Clinical-stage biopharma developing ADCs, immuno-oncology d…
|
141080 | KR | Professional, scientific and te… |
|
Linical Co., Ltd.
A global CRO providing a full spectrum of drug development …
|
2183 | JP | Professional, scientific and te… |
|
Lipigon Pharmaceuticals AB
A clinical-stage company developing therapeutics for lipid-…
|
LPGO | SE | Professional, scientific and te… |
Zentek Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34277/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34277 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34277 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34277 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34277}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zentek Ltd. (id: 34277)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.